Found: 17
Select item for more details and to access through your institution.
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Blurred lines: bilateral optic perineuritis mimicking idiopathic intracranial hypertension.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1783, doi. 10.1007/s10072-023-07215-8
- By:
- Publication type:
- Article
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11444-w
- By:
- Publication type:
- Article
Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6051, doi. 10.3390/ijms24076051
- By:
- Publication type:
- Article
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12440, doi. 10.3390/ijms232012440
- By:
- Publication type:
- Article
A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3696, doi. 10.3390/ijms22073696
- By:
- Publication type:
- Article
ADEM after ChAdOx1 nCoV-19 vaccine: A case report.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1151, doi. 10.1177/13524585211040222
- By:
- Publication type:
- Article
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.829331
- By:
- Publication type:
- Article
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis.
- Published in:
- Microorganisms, 2024, v. 12, n. 7, p. 1476, doi. 10.3390/microorganisms12071476
- By:
- Publication type:
- Article
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases.
- Published in:
- Microorganisms, 2021, v. 9, n. 6, p. 1132, doi. 10.3390/microorganisms9061132
- By:
- Publication type:
- Article
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1161849
- By:
- Publication type:
- Article
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.755333
- By:
- Publication type:
- Article
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.1018785
- By:
- Publication type:
- Article
Leukocyte Telomere Length Variability as a Potential Biomarker in Patients with PolyQ Diseases.
- Published in:
- Antioxidants, 2022, v. 11, n. 8, p. 1, doi. 10.3390/antiox11081436
- By:
- Publication type:
- Article
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 3, p. 325, doi. 10.1177/13524585241227119
- By:
- Publication type:
- Article
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis.
- Published in:
- Genes, 2020, v. 11, n. 1, p. 97, doi. 10.3390/genes11010097
- By:
- Publication type:
- Article
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5353, doi. 10.3390/ijms25105353
- By:
- Publication type:
- Article